flufenamic acid has been researched along with 2-(4-amylcinnamoyl)amino-4-chlorobenzoic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennis, K; Ducki, S; Lesage, F; Vivier, D | 1 |
| Jin, H; Jin, Z; Lin, H; Liu, Z; Xu, Q; Yang, W; Yu, P; Zhang, H; Zhang, L; Zhang, Y; Zhao, S | 1 |
1 review(s) available for flufenamic acid and 2-(4-amylcinnamoyl)amino-4-chlorobenzoic acid
| Article | Year |
|---|---|
Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target?
Topics: Arrhythmias, Cardiac; Depression; Epilepsy; Humans; Inflammation; Models, Molecular; Molecular Structure; Neuroprotective Agents; Pain; Potassium Channels, Tandem Pore Domain; Structure-Activity Relationship | 2016 |
1 other study(ies) available for flufenamic acid and 2-(4-amylcinnamoyl)amino-4-chlorobenzoic acid
| Article | Year |
|---|---|
The Discovery of Novel ACA Derivatives as Specific TRPM2 Inhibitors that Reduce Ischemic Injury Both In Vitro and In Vivo.
Topics: Animals; Cell Line, Tumor; Cinnamates; Glucose; HEK293 Cells; Humans; Infarction, Middle Cerebral Artery; Male; Mice, Inbred C57BL; Molecular Structure; Neuroprotective Agents; ortho-Aminobenzoates; Oxygen; Reperfusion Injury; Structure-Activity Relationship; TRPM Cation Channels | 2021 |